Fate Therapeutics, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT836 which is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, FT839, to treat complex autoimmune diseases; and FT825 to treat solid tumors. It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. The company was incorporated in 2007 and is headquartered in San Diego, California.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| TwoSigma | quant | 3.47M | $4.16M | 0.00% | Added+99.9% | 2026-03-31 |
| RenTech | quant | 2.97M | $3.57M | 0.01% | Added+26.0% | 2026-03-31 |
| StateStreet | passive | 2.26M | $2.72M | 0.00% | Unchanged | 2026-03-31 |
| FidelityFMR | fundamental | 47.6K | $57.11K | 0.00% | Added+273.1% | 2026-03-31 |
| Citadel | multi-strat | 43.1K | $51.74K | 0.00% | Trimmed-97.2% | 2026-03-31 |
| TRowePrice | fundamental | 76.6K | $92 | 0.00% | Added+40.7% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-11upcoming | -0.26 | — | — |
| 2026-05-13 | -0.28 | -0.26 | +5.45% |
| 2026-02-26 | -0.27 | -0.27 | +0.46% |
| 2025-11-13 | -0.28 | -0.27 | +4.33% |
| 2025-08-12 | -0.34 | -0.29 | +15.76% |
| 2025-05-13 | -0.38 | -0.32 | +15.66% |
| 2025-03-05 | -0.42 | -0.44 | -3.83% |
| 2024-11-12 | -0.41 | -0.40 | +2.95% |
| 2024-08-13 | -0.45 | -0.33 | +27.23% |
| 2024-05-09 | -0.45 | -0.47 | -3.88% |
| 2024-02-26 | -0.50 | -0.45 | +9.85% |
| 2023-11-08 | -0.56 | -0.46 | +17.88% |
| 2023-08-08 | -0.58 | -0.54 | +6.58% |
| 2023-05-03 | -0.62 | -0.19 | +69.30% |
| 2023-02-28 | -0.85 | -0.58 | +32.01% |
| 2022-11-03 | -0.87 | -0.86 | +0.73% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| FATE | +85.62% | +107.30% | +189.80% | +134.71% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | +82.65% | +111.94% | +193.24% | +122.02% |